Genetics of Primary Brain Tumors: a Review

Overview

Journal J Neurooncol

Publisher Springer

Date 1993 Jan 1

PMID 8057137

Citations 17

Authors

M Bondy

J Wiencke

M Wrensch

A P Kyritsis

Affiliations

Soon will be listed here.

Abstract

In this review we provide evidence for the existence of genes associated with primary malignant brain tumors. We summarize the current knowledge from studies of familial cancer aggregation, hereditary syndromes, and molecular and cytogenetic studies. The epidemiologic evidence is suggestive but inconclusive for an association between brain tumors and cancers in other family members, including cancers of the breast, lung and colon. Central nervous system (CNS) tumors have been associated with several hereditary syndromes including the Li-Fraumeni cancer family syndrome, neurofibromatosis (types 1 and 2), tuberous sclerosis, nevoid basal cell carcinoma syndrome, familial polyposis, and von Hippel-Lindau disease. Significant studies leading to the recognition of molecular and cytogenetic abnormalities in malignant gliomas are described in detail. The genetic studies conducted thus far suggest a role for inherited susceptibility in some CNS tumors.

Citing Articles

The Past, Present and Future of Flow Cytometry in Central Nervous System Malignancies.

Vartholomatos E, Vartholomatos G, Alexiou G, Markopoulos G Methods Protoc. 2021; 4(1).

PMID: 33530325 PMC: 7839046. DOI: 10.3390/mps4010011.

A Comprehensive Meta-analysis of Genetic Associations Between Key Polymorphic Loci in DNA Repair Genes and Glioma Risk.

Qi L, Yu H, Zhang Y, Ding L, Zhao D, Lv P Mol Neurobiol. 2016; 54(2):1314-1325.

PMID: 26843108 DOI: 10.1007/s12035-016-9725-5.

Genetic Contribution of Polymorphisms in Glutathione S-Transferases to Brain Tumor Risk.

Geng P, Li J, Wang N, Ou J, Xie G, Sa R Mol Neurobiol. 2015; 53(3):1730-1740.

PMID: 25735248 DOI: 10.1007/s12035-015-9097-2.

Brain and central nervous system cancer incidence in navarre (Spain), 1973-2008 and projections for 2014.

Etxeberria J, San Roman E, Burgui R, Guevara M, Moreno-Iribas C, Urbina M J Cancer. 2015; 6(2):177-83.

PMID: 25561983 PMC: 4280401. DOI: 10.7150/jca.10482.

DNA repair gene ERCC1 polymorphisms may contribute to the risk of glioma.

Yuan G, Gao D, Ding S, Tan J Tumour Biol. 2014; 35(5):4267-75.

PMID: 24453030 DOI: 10.1007/s13277-013-1557-6.

References

Humphrey P, Gangarosa L, Wong A, Archer G, Lund-Johansen M, Bjerkvig R . Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function. Biochem Biophys Res Commun. 1991; 178(3):1413-20. DOI: 10.1016/0006-291x(91)91051-d. View

Blatt J, Jaffe R, Deutsch M, Adkins J . Neurofibromatosis and childhood tumors. Cancer. 1986; 57(6):1225-9. DOI: 10.1002/1097-0142(19860315)57:6<1225::aid-cncr2820570627>3.0.co;2-p. View

Kuerbitz S, Plunkett B, Walsh W, Kastan M . Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A. 1992; 89(16):7491-5. PMC: 49736. DOI: 10.1073/pnas.89.16.7491. View

Diedrich U, Soja S, Behnke J, Zoll B . Amplification of the c-erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue. J Neurol. 1991; 238(4):221-4. DOI: 10.1007/BF00314785. View

Oren M . p53: the ultimate tumor suppressor gene?. FASEB J. 1992; 6(13):3169-76. DOI: 10.1096/fasebj.6.13.1397838. View

Ellison D, Gatter K, Steart P, Lane D, Weller R . Expression of the p53 protein in a spectrum of astrocytic tumours. J Pathol. 1992; 168(4):383-6. DOI: 10.1002/path.1711680408. View

Hurtt M, Moossy J, Locker J . Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol. 1992; 51(1):84-90. DOI: 10.1097/00005072-199201000-00010. View

Viskochil D, Buchberg A, Xu G, Cawthon R, Stevens J, Wolff R . Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990; 62(1):187-92. DOI: 10.1016/0092-8674(90)90252-a. View

Burch J, Craib K, Choi B, Miller A, Risch H, Howe G . An exploratory case-control study of brain tumors in adults. J Natl Cancer Inst. 1987; 78(4):601-9. View

10.

Libermann T, Nusbaum H, Razon N, Kris R, Lax I, Soreq H . Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature. 1985; 313(5998):144-7. DOI: 10.1038/313144a0. View

11.

Lynch H, MULCAHY G, Harris R, Guirgis H, Lynch J . Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma. Cancer. 1978; 41(5):2055-64. DOI: 10.1002/1097-0142(197805)41:5<2055::aid-cncr2820410554>3.0.co;2-x. View

12.

Khoury M, Flanders W . On the measurement of susceptibility to genetic factors. Genet Epidemiol. 1989; 6(6):699-711. DOI: 10.1002/gepi.1370060607. View

13.

Arnoldus E, Wolters L, Voormolen J, van Duinen S, Raap A, VAN DER PLOEG M . Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. J Neurosurg. 1992; 76(6):997-1003. DOI: 10.3171/jns.1992.76.6.0997. View

14.

Rubenstein A . Neurofibromatosis. A review of the clinical problem. Ann N Y Acad Sci. 1986; 486:1-13. DOI: 10.1111/j.1749-6632.1986.tb48057.x. View

15.

Fujimoto M, Fults D, Thomas G, Nakamura Y, Heilbrun M, White R . Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics. 1989; 4(2):210-4. DOI: 10.1016/0888-7543(89)90302-9. View

16.

Preston-Martin S, Mack W, Henderson B . Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Res. 1989; 49(21):6137-43. View

17.

Lewis J, Ginsberg A, Toomey K . Turcot's syndrome. Evidence for autosomal dominant inheritance. Cancer. 1983; 51(3):524-8. DOI: 10.1002/1097-0142(19830201)51:3<524::aid-cncr2820510326>3.0.co;2-i. View

18.

Bodmer W, Bailey C, Bodmer J, Bussey H, Ellis A, Gorman P . Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature. 1987; 328(6131):614-6. DOI: 10.1038/328614a0. View

19.

Jenkins R, Kimmel D, Moertel C, Schultz C, Scheithauer B, Kelly P . A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet. 1989; 39(2):253-79. DOI: 10.1016/0165-4608(89)90192-1. View

20.

Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D . Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science. 1987; 236(4805):1100-2. DOI: 10.1126/science.3107130. View